All In MedTech

FDA Clearance Tracker · P890027

NUCLEUS 22 CHANNEL COCHLEAR IMPLANT SYS /CHILDREN

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Jun 27, 1990 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Jun 27, 1990

Approved

Time to decision

408 days

Received May 15, 1989. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P890027
Device name
NUCLEUS 22 CHANNEL COCHLEAR IMPLANT SYS /CHILDREN
Applicant location
Lone Tree, CO
Received
May 15, 1989
Decided
Jun 27, 1990
Decision
Approved
Supplements
65 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code MCM

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MCM. The earliest in FDA's data is P830069, decided Nov 26, 1984.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Cochlear Americas

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.